And what a shocker … the Chief Scientific Advisor is none other than the Great Zerhouni (Katrina Kelner is the Editor, aided by Senior Editor Kelly LaMarco and an Advisory Board).
So what does the newest AAAS journal, whose “mission is to chronicle the conversion of basic biomedical research into practical applications,” want to publish?
The journal’s editorial team is seeking a variety of research papers, reviews, commentaries and other article formats in the following areas: cancer, cardiovascular disease, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, immunology/vaccines, infectious diseases, policy, behavior, bioengineering, physics, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, other interdisciplinary approaches to medicine.
Preference will be given to papers on humans, human tissue, and animal models with proven relevance to human diseases.
Hmmm. Did they leave anything out? We’ll soon see. The first issue of Science Translational Medicine (not to be confused with BMC’s open access Journal of Translational Medicine) is slated to go online on October 7th.
Of course, the Mission Statement & Purpose are pure GZ:
Mission statement: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.
Purpose: A profound transition is required for the science of translational medicine. Despite 50 years of advances in our fundamental understanding of human biology and the emergence of powerful new technologies, the rapid transformation of this knowledge into effective health measures continues to elude biomedical scientists. This paradox illustrates the daunting complexity of the challenges faced by translational researchers as they apply the basic discoveries and experimental approaches of modern science to the alleviation of human disease. Studies in humans often highlight deep gaps in our fundamental understanding of biology, but the linkages back to basic research to fill these gaps have not been as effective as they could be. Clearly, creative experimental approaches, novel technologies and new ways of conducting scientific explorations at the interface of established and emerging disciplines are now required to an unprecedented degree if real progress is to be made. Nothing short of a true reinvention of the science of translational medicine is likely to suffice. To aid in this reinvention, Science and AAAS have created a new interdisciplinary journal, Science Translational Medicine.
AAAS also kindly defines translational medicine, including specific examples.
Okay folks, go forth and reinvent yourselves (and don’t forget about the National New Biology Initiative as you do so).